Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
A2 Milk Market Set to Reach USD 90.77 Billion by 2035 at 17.75% CAGR as Health-Focused Dairy Demand Accelerates
EIN Presswire
The A2 Milk Market is projected to grow from USD 17.71 billion in 2025 to USD 90.77 billion by 2035, driven by health-focused dairy demand.
‘Busan Syndrome’ Gains Visibility as Busan, South Korea, Opens Citywide Night Festa
EIN Presswire
American visits to Busan up 76% this year as South Korea's leading coastal destination expands free nighttime programming through December.
Manuka Honey Market Reaches USD 1.291 Billion by 2035 at 6.0% CAGR as Natural Wellness Demand Accelerates
EIN Presswire
Manuka Honey Market is projected to grow from USD 0.7208 billion in 2025 to USD 1.291 billion by 2035 at a 6.0% CAGR, supported by natural wellness demand.
Flavor Market to Reach USD 34.0 Billion by 2035 at 6.40% CAGR as Natural and Health-Focused Flavors Drive Innovation
EIN Presswire
Flavor Market is projected to reach USD 34.0 billion by 2035, driven by natural ingredients, product innovation, & evolving consumer taste preferences.
Medical Aesthetics Market to reach USD 51.35 Billion by 2035 at 10.93% CAGR
EIN Presswire
Medical Aesthetics Market to Surge from USD 20.19 Billion in 2026 to USD 51.35 Billion by 2035—Powered by Rising Geriatric Population, Social Media Awareness NY, CA, UNITED STATES, August 26, 2026 /EINPresswire.com/ -- As per Market Research...
Ear Balance to Expand Specialist Audiology Care with New Thomson Medical Centre Clinic in 2027
EIN Presswire
SINGAPORE, SINGAPORE, August 24, 2026 /EINPresswire.com/ -- Ear Balance, a specialist hearing and balance clinic in Singapore, is preparing to expand its clinical services with the opening of a new clinic at Thomson Medical Center in January...
Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition
GlobeNewswire, Inc.
NBI-1117567 is an investigational oral, muscarinic M1 preferring (M1/M4) selective agonist discovered by Nxera and advancing through clinical development under a multi-program collaboration with Neurocrine Nxera to receive a US$10 million...
South Korea’s VandS Clinic Expands Multilingual Aesthetic Care for Global Tourists
EIN Presswire
VandS Clinic offers tailored diagnostic treatments and interpretation support across 68 South Korean branches to serve international travelers.
AB Plastic Surgery Clinic Reports 'Zero Medical Accidents,' Citing Integrated Patient Safety System
EIN Presswire
Korea based AB Plastic Surgery Clinic highlights its integrated approach to anesthesia, real time monitoring, emergency preparedness and patient safety.
Global Breakfast Cereals Market to Grow to USD 79.77 Billion by 2035 as Nutrition Trends Reshape Demand
EIN Presswire
Front-of-pack nutrition initiatives, premium nutrition positioning and Asia-Pacific expansion are creating new opportunities across the global cereal industry.
US Digital Mental Health Market to reach USD 47.72 Billion by 2035 at 21.5% CAGR
EIN Presswire
US Digital Mental Health Market to Surge from USD 6.806 Billion in 2025 to USD 47.72 Billion by 2035 — Driven by Teletherapy Expansion, AI Integration NY, CA, UNITED STATES, August 25, 2026 /EINPresswire.com/ -- As per Market Research Future,...
AB Plastic Surgery Showcases Korean Facelift Techniques at 2026 IFAAS
EIN Presswire
AB Plastic Surgery presented Full SMAS Facelift, Neck Lift and Submentoplasty techniques during a live surgery session at IFAAS 2026 in Seoul.
Guidewires Market to reach USD 3.73 Billion by 2035 at 4.82% CAGR
EIN Presswire
Guidewires Market to Surge from USD 2.33 Bn in 2025 to USD 3.73 Bn by 2035—By Rising Cardiovascular Disease Prevalence, Minimally Invasive Procedure Adoption NY, CA, UNITED STATES, August 28, 2026 /EINPresswire.com/ -- As per Market Research...
Gas Chromatography Market to reach USD 7.81 Billion by 2035 at 5.6% CAGR
EIN Presswire
Gas Chromatography Market to Surge from USD 4.53 Bn in 2025 to USD 7.81 Bn by 2035—By Stricter Pharmaceutical Quality Mandates, Hydrogen Carrier-Gas Transition NY, CA, UNITED STATES, August 28, 2026 /EINPresswire.com/ -- As per Market Research...
MIMOSU Wins 2026 Seoul Award for Fermented Rice Water Hair Care: Clean Scalp Rituals for Hair Retention
EIN Presswire
Clean scalp care brand MIMOSU receives the Seoul Award for Outstanding Product, refining traditional Korean rice water into low-pH formulas.
SNU Eye Clinic Highlights Precision Planning in Toric ICL Surgery
EIN Presswire
SNU Eye Clinic emphasizes personalized Toric ICL planning and precise lens alignment to minimize residual astigmatism and improve vision correction outcomes.
Melixir Brings Korea’s Plant-Based Skincare Philosophy to New York at Seoul to Soho
EIN Presswire
Korea’s pioneering vegan skincare brand showcases its approach to sensitive skin, sustainability and modern K-beauty at the month-long SoHo experience NEW YORK, NY, UNITED STATES, August 24, 2026 /EINPresswire.com/ -- Melixir, the Korean...
Olympian Joetta Clark Diggs to Compete at World Masters Athletics Championships in Daegu, South Korea
EIN Presswire
Decorated Olympian and American record-holder will compete in the 100-meter and 200-meter events on the international masters stage BETHLEHEM, PA, UNITED STATES, August 20, 2026 /EINPresswire.com/ -- Four-time U.S. Olympian, 11-time USA national...
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
GlobeNewswire, Inc.
FULLERTON, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”), a biotechnology company developing innovative cancer therapies, today announced that it has engaged Synex Consulting Ltd....
LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease
GlobeNewswire, Inc.
TOKYO and CAMBRIDGE, Mass., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced today that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in the U.S. for...
Sign up for:
Health Daily South Korea
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.